0001209191-18-045745.txt : 20180807
0001209191-18-045745.hdr.sgml : 20180807
20180807175356
ACCESSION NUMBER: 0001209191-18-045745
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180806
FILED AS OF DATE: 20180807
DATE AS OF CHANGE: 20180807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cavanagh Shawn
CENTRAL INDEX KEY: 0001353221
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10638
FILM NUMBER: 18999326
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: EAST RUTHERFORD
STATE: NJ
ZIP: 07073
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAMBREX CORP
CENTRAL INDEX KEY: 0000820081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222476135
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MEADOWLANDS PLZ
CITY: E RUTHERFORD
STATE: NJ
ZIP: 07073
BUSINESS PHONE: 2018043000
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: E. RUTHERFORD
STATE: NJ
ZIP: 07073
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-06
0
0000820081
CAMBREX CORP
CBM
0001353221
Cavanagh Shawn
ONE MEADOWLANDS PLAZA
EAST RUTHERFORD
NJ
07073
0
1
0
0
EVP & COO
Common Stock
2018-08-06
4
M
0
10000
16.905
A
27658
D
Common Stock
2018-08-06
4
M
0
10000
17.81
A
37658
D
Common Stock
2018-08-06
4
M
0
17500
41.355
A
55158
D
Common Stock
2018-08-06
4
M
0
399
40.65
A
55557
D
Common Stock
2018-08-06
4
S
0
29155
62.11
D
26402
D
Common Stock
2018-08-06
4
S
0
8744
63.16
D
17658
D
Common Stock
2018-08-07
4
M
0
8351
40.65
A
26009
D
Common Stock
2018-08-07
4
S
0
8351
62.89
D
17658
D
Stock Option (right to buy)
16.905
2018-08-06
4
M
0
10000
0.00
A
2020-10-28
Common Stock
10000
0
D
Stock Option (right to buy)
17.81
2018-08-06
4
M
0
10000
0.00
A
2021-10-22
Common Stock
10000
10000
D
Stock Option (right to buy)
41.355
2018-08-06
4
M
0
17500
0.00
A
2022-10-21
Common Stock
17500
17500
D
Stock Option (right to buy)
40.65
2018-08-06
4
M
0
399
0.00
A
2023-10-26
Common Stock
399
34601
D
Stock Option (right to buy)
40.65
2018-08-07
4
M
0
8351
0.00
A
2023-10-26
Common Stock
8351
26250
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.65 to $62.65 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.70 to $63.50 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
The option representing a right to purchase 40,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted
The option representing a right to purchase 40,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted.
The option representing a right to purchase 35,000 shares became exercisable in four equal installments beginning October 21, 2016, which was the first anniversary of the date on which the option was granted.
The option representing a right to purchase 35,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted.
/s/ Samantha Hanley for Shawn Cavanagh by POA
2018-08-07